Biotechnology News

October 29, 2012

DURHAM, N.C.--(BUSINESS WIRE)--PharPoint Research was named one of the 50 fastest growing private companies in the Raleigh-Durham area for the second year in the row by the Triangle Business Journal.

October 29, 2012

VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that Lawrence C. Marsh, 52, will join the company in the new role of Chief Strategy Officer and Senior Vice President, New Market Development, effective...

October 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Reschedules its Third Quarter 2012 Financial Results Conference Call and Webcast Due to Hurricane Sandy

October 29, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

October 29, 2012

RICHMOND, Va. & NORFOLK, Va.--(BUSINESS WIRE)--The Environmental Protection Agency Supports Claim that Cupron Enhanced EOS Can Kill 99.9% of Bacteria in Under Two Hours.

October 29, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the total number of diagnosed incident cases of prostate cancer in Russia will...

October 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ensemble poster presentation on orally active small molecule antagonists of Interleukin-17 at American College of Rheumatology (ACR) 2012, November 13, 2012

October 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra CMO, Donna Ambrosino, MD, has been invited to present VIS410 at the Int'l Society for Influenza and Other Respiratory Virus Diseases (isirv) Conference in Hanoi, Viet Nam 10/29-31 2012.

October 29, 2012

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy for the early identification and treatment of cancer, today announced growing demand for and adoption of its Xoft® Axxent®...

October 29, 2012

NEW YORK & LAUSANNE, Switzerland--(BUSINESS WIRE)--Celtic Therapeutics, the global private equity firm focused on novel therapeutic product candidates, announced that Beth P. Hecht has joined as a Partner and Chief Legal and Administrative...

October 29, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex makes significant advances in the field of protein-based vaccine development. Dendritic cell targeted vaccine CDX-1401 elicits robust antibody
and T cell responses. Data at SITC 2012.

October 29, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (OTCBB:ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-...

October 29, 2012

ATLANTA--(BUSINESS WIRE)--Clearside Biomedical Inc. of Atlanta, an ophthalmic pharmaceutical company developing targeted therapeutics for the treatment of sight-threatening diseases, announces its new CFO.

October 29, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX: NDN) (NYSE: NDZ) announced today that it has been granted special permission by The Open Joint Stock Company “Isotope” (Isotope), the authorized subsidiary of Russia’s State Atomic Energy...

October 29, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research presents data on subcutaneous formulation of DPC siRNA delivery system showing unprecedented knockdown without toxicity. Potential leap forward for RNAi therapeutics

October 29, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or...

October 29, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today announced that a per protocol interim safety review on Friday, October 26, 2012, by an independent Data Safety Monitoring Board (DSMB) recommended that GTx continue clinical...

October 29, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Nonclinical data on antitumor immune response to PV-10 immuno-chemoablation was presented at the SITC Annual Meeting in Baltimore on October 26th.

October 29, 2012

--(BUSINESS WIRE)--Kef Kasdin, CEO, Proterro, Inc., developer of fermentation-ready sugar for economical/scalable production of biofuels + biobased chemicals, to discuss feedstock economics at Adv. Biofuels Markets 2012

October 29, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that, due to severe weather on the East Coast of the United States, it will postpone its third quarter 2012 financial results press release and conference...

October 29, 2012

CLEVELAND--(BUSINESS WIRE)--Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports...

October 29, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Genome Engineering Patent Allowance

October 29, 2012

STOCKHOLM--(BUSINESS WIRE)--World Psoriasis Day, October 29, 2012 Psoriasis is a serious, inflammatory, noncommunicable disease, associated with an increased risk of developing severe co-morbid conditions such as cardiovascular disease, diabetes...

October 29, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) reported today its sales for the third quarter and the first nine months of 2012. Third quarter and first nine months 2012 consolidated sales2     Third...

October 29, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta, (STO:EKTAB) a world leader in the design and manufacture of cancer treatment technology and software, and MSM-MEDIMPEX, a major Russian medical technology distributor, have announced their...

October 29, 2012

LONDON--(BUSINESS WIRE)--Latin America remains at risk of a devastating stroke crisis, according to regional health experts launching two new Reports published today, on World Stroke Day, by Action for Stroke Prevention (ASP). Building on ASP’s...

October 29, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis (Paris:ALCLS) (Alternext: ALCLS), the genome engineering specialist, has announced successfully programming cells from the immune system (T cells) to kill cancer cells. This technological...

October 29, 2012

GOETTINGEN, Deutschland--(BUSINESS WIRE)--Sartorius, a leading international laboratory and pharmaceutical equipment provider, successfully closed the first nine months of 2012, with substantial gains in order intake, sales revenue and earnings....

October 28, 2012

LONDON--(BUSINESS WIRE)--The UK remains at risk of a devastating stroke crisis, according to UK health experts launching Reports published today, on World Stroke Day, by Action for Stroke Prevention (ASP), an alliance of renowned health experts...

October 28, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announces the postponement of the issuance of its Third Quarter 2012 Performance Report and webcast of a conference call with investment analysts, which was previously scheduled for Tuesday, October 30, 2012...

October 28, 2012

LONDON--(BUSINESS WIRE)--Europe remains at risk of a devastating stroke crisis, according to a major new Report, “How Can We Avoid a Stroke Crisis in Europe?” published today, on World Stroke Day, by Action for Stroke Prevention (ASP). Alarmingly...

October 28, 2012

LONDON--(BUSINESS WIRE)--Asia-Pacific remains at risk of a devastating stroke crisis, according to regional health experts launching two new Reports published today, on World Stroke Day, by Action for Stroke Prevention (ASP). Building on ASP’s...

October 28, 2012

BOSTON--(BUSINESS WIRE)--Integration of the Philips Ambient Experience into an IBA proton therapy system is being featured at the 54th annual meeting of ASTRO, the American Society for Radiation Oncology, in Boston.

October 26, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next...

October 26, 2012

PORTLAND, Ore.--(BUSINESS WIRE)--CytoDyn Moves Corporate Headquarters to Oregon

October 26, 2012

SAN DIEGO--(BUSINESS WIRE)--Medistem, discoverer of menstrual blood stem cells called the ERC, are presenting clinical trial data at the prestigious conference Stem Cells on the Mesa

October 26, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics Schedules Third Quarter 2012 Financial Results and Conference Call for November 8, 2012

October 26, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) and Forest Laboratories Holdings, Ltd. (collectively, “Forest”) announced today that they have entered into a settlement agreement with Hetero Labs Ltd. and Hetero USA Inc. (...

October 26, 2012

NORCROSS, Ga.--(BUSINESS WIRE)--Galectin Therapeutics will present preclinical data on its liver fibrosis candidate, GR-MD-02, at AASLD 2012.

October 26, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) approved SYNRIBO (omacetaxine mepesuccinate) for Injection to treat adult patients with chronic phase (...

October 26, 2012

--(BUSINESS WIRE)--Southern Research Institute is a not-for-profit 501(c)(3) scientific research organization founded in 1941 that conducts preclinical drug discovery and development, advanced engineering research in materials, systems...

October 26, 2012

--(BUSINESS WIRE)--Vilex in Tennessee, Inc. (Vilex®) is a privately-owned company, headquartered in McMinnville, Tennessee. The main business of Vilex is orthopedic and podiatric bone surgery. Vilex offers a broad range of cannulated screws,...

October 26, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-U.S. and Non-U.K. Media Boehringer Ingelheim and Eli Lilly and Company today announced that the European Commission has approved an expanded therapeutic indication for the DPP-4 inhibitor Trajenta® (...

October 26, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq: RTIX), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, is launching a new biologic implant for use in sports medicine,...

October 26, 2012

LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories Inc. (Nasdaq: CBRX) today confirmed that the U.S. Food and Drug Administration (FDA) has denied Watson Pharmaceuticals’ (NYSE:WPI) Formal Dispute Resolution Request (FDRR) related to its...

October 26, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that chairman and CEO Gary Rabin will present at the 2012 Stem Cell Meeting on the Mesa’s...

October 26, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) announced today that it will report financial results for the third quarter ended September 30, 2012 on Thursday, November 8, 2012. Company management will host a...

October 26, 2012

SAN DIEGO--(BUSINESS WIRE)--Cytori will be giving a corporate presentation from the Stem Cell Meeting on the Mesa Investors & Partnering Forum on Tuesday, October 30 at 1:45 PT.

October 26, 2012

WASHINGTON--(BUSINESS WIRE)--eClinicalWorks’ customer Coastal Medical, founded in Providence, R.I., has received a 2012 Ambulatory HIMSS Davies Award of Excellence.